-
-
Overview
-
Saralasin [(Sar1,Val5,Ala8)-Angiotensin II], a peptide compound, is a partial agonist/competitive non-selective antagonist of angiotensin II receptors, though it is commonly mistaken as a competitive antagonist.
Saralasin's distinction as a partial agonist is based on the fact that
its therapeutic effect (i.e. reduced hypertension) is only observed in
patients with high plasma angiotensin II levels, but in patients with
low angiotensin II levels Saralasin causes hypertension. In other words,
the effects of Saralasin on the angiotensin II receptor in the absence
of angiotensin II is pharmacodynamically similar to angiotensin II
itself thus it is a partial agonist, because if it was an antagonist it
would not elicit an effect when bound to its receptor. Saralasin is an
angiotensin II analogue, containing sarcosine-1 and alanine-8, hence the name (sarcosine, alanine, angiotensin).Please contact us at for specific academic pricing.
-
- Properties
-
Overview